AU636488C - Use of a 1-2(-naphthylethyl)-4-(3-trifluoromethylphenyl)-1, 2,3,6-tetrahydropyridine for the treatment of cerebral and n euronal diseases
- Google Patents
Use of a 1-2(-naphthylethyl)-4-(3-trifluoromethylphenyl)-1, 2,3,6-tetrahydropyridine for the treatment of cerebral and n euronal diseases
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9006399Aexternal-prioritypatent/FR2662355B1/en
Application filed by Sanofi Aventis FrancefiledCriticalSanofi Aventis France
Publication of AU7713391ApublicationCriticalpatent/AU7713391A/en
Application grantedgrantedCritical
Publication of AU636488B2publicationCriticalpatent/AU636488B2/en
Publication of AU636488CpublicationCriticalpatent/AU636488C/en
Assigned to SANOFI-SYNTHELABOreassignmentSANOFI-SYNTHELABORequest to Amend Deed and RegisterAssignors: SANOFI
Assigned to SANOFI-AVENTISreassignmentSANOFI-AVENTISRequest to Amend Deed and RegisterAssignors: SANOFI-SYNTHELABO
AU77133/91A1990-05-221991-05-20Use of a 1-2(-naphthylethyl)-4-(3-trifluoromethylphenyl)-1, 2,3,6-tetrahydropyridine for the treatment of cerebral and n euronal diseases
ExpiredAU636488C
(en)
USE OF 1- [2- (2-NAPHTYL) ETHYL] -4- (3-TRIFLUOROMETHYLPHENYL) -1,2,3,6-TETRAHYDROPYRIDINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF BRAIN AND NEURAL DISORDERS.